Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 49

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 49
---
 Accounts receivable3,943 (11,517)Inventories(36,213)9,416 Prepaid expenses and other current assets(4,721)(11,188)Other assets(7,149)(17,540)Accounts payable23,328 21,086 Accrued liabilities(28,887)20,484 Income taxes, including excess tax benefits and deferred income taxes(33,501)4,360 Net cash provided by operating activities119,248 163,841 CASH FLOWS FROM INVESTING ACTIVITIES:  Purchases of property, plant and equipment(63,397)(55,292)Proceeds from sale of business211,185 — Proceeds from sale of assets42 695 Intangible asset additions(7,210)(8,317)Proceeds from sale and maturities of investment securities— 500 Net cash provided by (used in) investing activities140,620 (62,414)CASH FLOWS FROM FINANCING ACTIVITIES:  Principal repayments of long-term debt(272,750)(38,250)Proceeds from exercise of stock options5,972 5,883 Payments on finance leases(1,543)(775)Payments of contingent earn-out liability— (2,600)Tax withholding payments related to net share settlement of equity awards(8,719)(11,867)Net cash used in financing activities(277,040)(47,609)Effect of exchange rate changes on cash8,338 4,472 NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS(8,834)58,290 CASH AND CASH EQUIVALENTS, beginning of period308,566 254,222 CASH AND CASH EQUIVALENTS, end of period$299,732 $312,512 

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - CONTINUED

(In thousands)

Nine months ended September 30,20252024SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING ACTIVITIES:  Purchases of property, plant, and equipment in accounts payable$5,544 $4,